These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1404867)

  • 21. In vitro amplification of hypervariable DNA regions for the evaluation of chimerism after allogeneic BMT.
    Martinelli G; Trabetti E; Zaccaria A; Farabegoli P; Buzzi M; Testoni N; Calori E; Bandini G; Rosti G; Belardinelli A
    Bone Marrow Transplant; 1993 Aug; 12(2):115-20. PubMed ID: 8401355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid dot-blot assay to assess chimerism following sex-mismatched bone marrow transplantation.
    Lawler M; McCann SR; DeArce MA; Humphries P
    Bone Marrow Transplant; 1988 Sep; 3(5):473-82. PubMed ID: 3056554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixed hematopoietic chimerism after allogeneic bone marrow transplantation: the impact of quantitative PCR analysis for prediction of relapse and graft rejection in children.
    Bader P; Hölle W; Klingebiel T; Handgretinger R; Benda N; Schlegel PG; Niethammer D; Beck J
    Bone Marrow Transplant; 1997 Apr; 19(7):697-702. PubMed ID: 9156247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [DNA polymorphisms as implant markers in allogeneic bone marrow transplantation. Preliminary evaluation].
    Brunet S; Casals T; Madoz P; Aventín A; Muñiz E; Baiget M
    Med Clin (Barc); 1989 Dec; 93(20):765-71. PubMed ID: 2576089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Application of sequential and quantitative monitoring of chimerism in allogeneic hematopoietic stem cell transplantation].
    Tang XW; Wu DP; Zhu ZL; Wang W; Sun AN; Qiu HY; Fu ZZ; Chang WR; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2004 Feb; 25(2):78-81. PubMed ID: 14990044
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Complete donor T cell chimerism is accomplished in patients transplanted with bone marrow grafts containing a fixed low number of T cells.
    Verdonck LF; van Blokland WT; Bosboom-Kalsbeek EK; van Heugten HG; Tilanus MG; de Weger RA
    Bone Marrow Transplant; 1996 Aug; 18(2):389-95. PubMed ID: 8864451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [DNA polymorphism, allogenic bone marrow transplantation and peripheral cell chimerism].
    Brdicka R; Sieglová Z; Honzátková L; Dvoráková R; Hrabánek J; Kobylka P; Vítek A; Sedlácek P; Starý J
    Cas Lek Cesk; 1998 Feb; 137(4):110-9. PubMed ID: 9531733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential molecular monitoring of chimerism in chronic myeloid leukemia patients receiving donor lymphocyte transfusion for relapse after bone marrow transplantation.
    Rapanotti MC; Arcese W; Buffolino S; Iori AP; Mengarelli A; De Cuia MR; Cardillo A; Cimino G
    Bone Marrow Transplant; 1997 Apr; 19(7):703-7. PubMed ID: 9156248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a single probe for documentation of chimerism following bone marrow transplantation.
    Yam P; Petz LD; Ali S; Stock AD; Wallace RB
    Am J Hum Genet; 1987 Nov; 41(5):867-81. PubMed ID: 2890295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
    Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
    Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the conditioning regimen on erythrocyte chimerism, graft-versus-host disease and relapse after allogeneic transplantation with lymphocyte depleted marrow.
    Bär BM; Schattenberg A; De Man AJ; Hoogenhout MJ; Boezeman J; de Witte T
    Bone Marrow Transplant; 1992 Jul; 10(1):45-52. PubMed ID: 1515878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia.
    Elmaagacli AH; Becks HW; Beelen DW; Stockova J; Bützler R; Opalka B; Schaefer UW
    Bone Marrow Transplant; 1995 Dec; 16(6):823-9. PubMed ID: 8750276
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of mixed hematopoietic chimerism in pediatric patients with leukemia after allogeneic stem cell transplantation by quantitative PCR analysis of variable number of tandem repeat and testis determination gene.
    Wang LJ; Chou P; Gonzalez-Ryan L; Huang W; Haut PR; Kletzel M
    Bone Marrow Transplant; 2002 Jan; 29(1):51-6. PubMed ID: 11840144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Repetitive DNA polymorphisms in following chimerism after allogeneic bone marrow transplantation.
    Grubic Z; Stingl K; Cecuk Jelicic E; Zunec R; Kastelan A; Serventi Seiwerth R; Bogdanic V; Labar B; Kerhin Brkljacic V
    Clin Transplant; 2005 Oct; 19(5):586-90. PubMed ID: 16146548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation.
    Antin JH; Childs R; Filipovich AH; Giralt S; Mackinnon S; Spitzer T; Weisdorf D
    Biol Blood Marrow Transplant; 2001; 7(9):473-85. PubMed ID: 11669214
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.
    Briones J; Urbano-Ispizua A; Lawler M; Rozman C; Gardiner N; Marín P; Salgado C; Féliz P; McCann S; Montserrat E
    Exp Hematol; 1998 May; 26(5):415-20. PubMed ID: 9590658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH; Beelen DW; Kroll M; Trzensky S; Stein C; Schaefer UW
    Bone Marrow Transplant; 1998 Jan; 21(2):159-66. PubMed ID: 9489633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Application of FBC conditioning regimen in HLA haplotype peripheral blood stem cell transplantation].
    Wu B; Guo K; Song Z; Yan D; Yang Y; Xiao L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):194-7. PubMed ID: 12133456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Application of microsatellite markers for monitoring of reconstitution pattern in patients after bone marrow transplantation/peripheral blood progenitor cell transplantation.
    Jungerman M; Sedzimirska M; Lange A; Witt M
    Arch Immunol Ther Exp (Warsz); 1998; 46(1):39-43. PubMed ID: 9510945
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of chimerism in long-term survivors after bone marrow transplantation for severe acquired aplastic anemia.
    Casado LF; Steegmann JL; Picó M; Requena MJ; Ramirez M; Madero L; Vicario JL; Alegre A; Gómez C; Fernández-Rañada JM
    Bone Marrow Transplant; 1996 Aug; 18(2):405-9. PubMed ID: 8864453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.